Agenus Inc., a scientific-phase biotechnology company, discovers and develops therapies to activate the human body's immune process in opposition to cancer and infections in the United States and internationally. It offers Retrocyte Display screen, an antibody expression System for the identification of thoroughly human and humanized monoclonal ant